Fundraising Fox

Dimension Inx

Chicago, US · Founded 2020 · 6 known investors

dimensioninx.com ↗

Dimension Bio is a biotechnology company that designs and manufactures regenerative therapeutics using its BioNidum™ platform to restore tissue function lost to disease, trauma, or aging. The platform combines materials science, 3D printing, and digital manufacturing to create biosynthetic and biohybrid scaffolds for implantable and injectable products across sports medicine, orthopedics, plastic surgery, dental, and cell therapy applications.

BiotechHealthtechNew Materialsin /dimension-bio

Founders & leadership

CN
Caralynn Nowinski Collens, M.D.Co-founder & CEO
RS
Ramille Shah, Ph.D.Co-founder & CSO
RC
Rima ChakrabartiDirector
RS
Ramille ShahDirector
CC
Caralynn CollensExecutive Officer, Director

Investors · 6

Better Ventures Central LlcOakland · $500K – $1.5M
Lofty VenturesChicago · $10K – $100K
Pathway BioventuresChicago
Portal InnovationsChicago
Solas BioVenturesChattanooga
KdT VenturesreportedAustin · $500K – $3M

Reported raises · per SEC filings

Form D private placements
▶$12MraisedFeb 2023 · 17 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Rima ChakrabartiDirector
  • Ramille ShahDirector
  • Caralynn CollensExecutive Officer, Director
Offering amount
$15M
Amount sold
$12M
First sale
Jan 2023
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.3MraisedNov 2021 · 18 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Caralynn CollensExecutive Officer, Director
  • Ramille ShahExecutive Officer, Director
  • Adam JakusExecutive Officer, Director
Offering amount
$2.3M
Amount sold
$2.3M
First sale
Nov 2021
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.4MraisedNov 2020 · 22 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Caralynn CollensExecutive Officer, Director
Offering amount
$3.4M
Amount sold
$3.4M
First sale
Nov 2020
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.